NioCorp: The Market Is Paying About 50 Cents Above Cash For Elk Creek

The author rates NioCorp Developments a buy with an $8.29-per-share target, arguing the market values Elk Creek at just $72M versus its estimated $3.44B after-tax NPV. The feasibility study projects $608M in average annual EBITDA, a 22.8% IRR and a 40-year mine life, while capex has risen to $1.849B. The author identifies financing as the critical risk.

Analysis

The headline “discount” is not, by itself, evidence of mispricing: project NPV is not equity value. The gap can rationally reflect the financing bridge, dilution to fund $1.849B of capex, schedule and construction risk, and uncertainty that feasibility-study commodity and operating assumptions survive execution. The key asymmetry is that financing terms—not a small change in modeled NPV—could dominate NB’s per-share outcome. A strategic partner, binding offtake, or credible public funding could de-risk the project and improve bargaining power; expensive equity or debt could transfer much of the project’s modeled value away from current shareholders. Potential downstream beneficiaries of secure domestic niobium, scandium, and titanium supply may have an incentive to support development, but that is only a hypothesis until commitments are disclosed.

Near term, treat the bullish valuation case as an analyst scenario, not independently verified value. Over 1–3 months, monitor financing, offtake, permitting, and any updated capital-cost or schedule disclosure. Over 6–18 months, the structural question is whether Elk Creek can secure capital on terms that preserve meaningful value per share. The contrarian point: a large NPV-to-equity-value gap may signal financing optionality, but it may also be the market’s price for severe funding and execution risk. Reassess if disclosed funding materially reduces the equity burden; the thesis weakens further with capex escalation, delays, weaker assumed commodity economics, or highly dilutive terms.

Key Decisions for Investors

• Do not underwrite the cited $8.29 target or NPV gap without checking the feasibility study’s discount rate, commodity-price assumptions, production ramp, remaining pre-production spend, and the exact basis of the quoted $72M project valuation.
• Keep NB on a financing-event watchlist rather than initiating a valuation-driven core long. Consider only a small, risk-budgeted speculative position after credible funding terms and offtake support are disclosed; avoid treating prospective government or strategic backing as committed.
• Track dilution sensitivity: compare any proposed equity raise, debt service, partner economics, and project-level ownership against fully diluted shares and remaining funding needs. A financing announcement can be negative for existing equity even if it advances construction.
• Falsification / risk triggers: further capex or schedule increases, failure to secure a financeable package, materially dilutive terms, or weaker project assumptions. A binding funding package that covers the capital plan on transparent terms would be the clearest evidence against the market’s current financing-risk discount.